학술논문
Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients
Document Type
Artikel
Author
Source
Annals of neurology. 87(5):688-699
Subject
Language
English
English
English
ISSN
1531-8249